Dr. Albo joined the Augusta University team in August 2015. He currently serves as the Jarrell Distinguished Chair in Surgical Oncology at the Georgia Cancer Center. He serves as the surgeon-in-chief for Augusta University Health System.
Dr. Albo’s clinical expertise is on minimally invasive surgical oncology with emphasis on colorectal surgery. He has one of the highest utilization rates for laparoscopic surgery in patients with colon and rectal cancer in the US, resulting in significant outcomes advantages for patients, including less pain, faster and more complete recoveries, and lower rate of wound complications.
Areas of Expertise (8)
Minimally Invasive Surgery
Media Appearances (3)
Medical College of Georgia names new surgery chairman
The Augusta Chronicle print
The Medical College of Georgia at Augusta University has named a new Department of Surgery chairman. Dr. Daniel Albo, a surgical oncologist, educator and the current vice chairman of the department, will take over the chairman post July 1, according to a news release from the school.
Putting the puzzle pieces into place: How a surgical oncologist’s personal experience helped to revolutionize cancer care
Your Health Today - Augusta University online
Dr. Daniel Albo shares the story of his son, who died from brain cancer, and how being involved in his care played a part in his passion for helping every cancer patient he treats.
New administrative appointments at Georgia Cancer Center at Augusta University
Jagwire - Augusta University online
Dr. Daniel Albo has been named director of the Cancer Service Line for the Georgia Cancer Center.
A multidisciplinary cancer center maximizes surgeons' impact.Journal of Surgical Research
Marshall CL1, Balentine CJ, Robinson CN, Wilks JA, Anaya D, Artinyan A, Awad SS, Berger DH, Albo D.
Our study suggests that although the recruitment of specialty-trained surgeons in a high volume center leads to improvement in surgical oncologic care, it is the establishment of a multidisciplinary center around the surgeons that leads to integrated care and improvements in oncologic outcomes.
Targeting Surgical Site Infection–Reducing Bundles Selectively to At-Risk Colon Cancer Surgery PopulationsJAMA Surgery
Daniel Albo, MD, PhD.
Surgical site infections (SSIs), a vexing problem in colon surgery, increase morbidity and significantly increase the cost of care. In an elegant article in this issue of JAMA Surgery, Amri et al1 evaluate their patient population at a large tertiary care facility for patient and perioperative risk factors that may increase SSIs after colon cancer surgery.
Racial disparities in the use of laparoscopic surgery to treat colonic diverticulitis Are not fully explained by socioeconomics or disease complexityThe American Journal of Surgery
Randi L.LassiterM.D.AsifTalukderM.D.Meryl M.AbramsB.S.Bao-LingAdamPh.D.DanielAlboM.D., Ph.D.Cassandra Q.WhiteM.D.
Several studies have demonstrated favorable outcomes for laparoscopic surgery over open surgery for the treatment of diverticular disease. This study was designed to analyze the relationship between race, socioeconomic status and the use of laparoscopy to address diverticulitis.